Peripheral blood inflammatory score using a cytokine multiplex assay predicts clinical outcomes in patients treated with atezolizumab-bevacizumab for unresectable HCC by Hee Sun Cho, Hee Sun Cho, Hee Sun Cho, Soon Kyu Lee, Soon Kyu Lee, Ji Won Han, Ji Won Han, Jung Hyun Kwon, Jung Hyun Kwon, Soon Woo Nam, Soon Woo Nam, Jaejun Lee, Jaejun Lee, Keungmo Yang, Keungmo Yang, Pil Soo Sung, Pil Soo Sung, Jeong Won Jang, Jeong Won Jang, Seung Kew Yoon, Seung Kew Yoon, Jong Young Choi, Jong Young Choi

Get full text